Abstract
Two peptide ligands conjugated adenine, [9-N-(tritylmercapto acetyl diglycyl aminoethyl) adenine, Tr-MAG2-Ade] and [9-N-(tritylmercapto acetyl triglycyl aminoethyl) adenine, Tr-MAG3-Ade], are synthesized and labeled with 99mTc by directly labeling method. The stability of 99mTc-MAG2-adenine and 99mTc-MAG3-adenine in vitro is measured. The uptake radios of tumor to muscle at 3h post-injection are 5.70 and 4.92, respectively. The biodistribution and scintigraphic imaging studies show that the two complexes have high localization in tumor and high contrasted tumor images can be obtained, which suggest their potential utility as tumor imaging agents. But the high radioactivity of abdomen could prevent the tumor imaging in this area.
Similar content being viewed by others
References
R. E. Weiner, M. L. Thakur, Appl. Radiation Isotopes, 57 (2002) 749.
X. Y. Chen, R. Park, A. H. Shahinian, Nucl. Med. Biol., 31 (2004) 179.
J. G. McAfee, R. D. Neumann, Nucl. Med. Biol. 23 (1996) 673.
S. Liu, S. Edwards, Chem. Rev., 99 (1999) 2235.
S. M. Okarvi, Nucl. Med. Comm., 20 (1999) 1093.
T. M. Behr, Quart. J. Nucl. Med., 45 (2001) 189.
J. Toyohara, Y. Fujibayashi, Nucl. Med. Biol., 30 (2003) 681.
C. M. Qi, L. C. Yang, H. B. Zhang et al., Med. Chem. Res., 11 (2002) 345.
Y. L. Zhao, C. L. Zhang, C. M. Qi et al., J. Beijing Normal University (Natural Science) 2 (2005) 166 (in Chinese).
R. F. Schneider, G. Subramanian, T. A. Feid et al., J. Nucl. Med., 25 (1984) 223.
S. Ilgan, J. David, P. D. Yang et al., Cancer Biother. Radiol., 13 (1998) 427.
Y. L. Zhao, G. R. You, C. M. Qi, J. Beijing Normal University (Natural Science) 4 (2005) 397 (in Chinese).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhao, Y.L., Zhang, C.L., Qi, C.M. et al. Synthesis and biodistribution of 99mTc-peptides conjugated adenine as tumor imaging agents. J Radioanal Nucl Chem 273, 9–13 (2007). https://doi.org/10.1007/s10967-007-0702-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-007-0702-3